The pharmacology of Parkinson's disease: Basic aspects and recent advances
β Scribed by M. Da Prada; H. H. Keller; L. Pieri; R. Kettler; W. E. Haefely
- Publisher
- Springer
- Year
- 1984
- Tongue
- English
- Weight
- 963 KB
- Volume
- 40
- Category
- Article
- ISSN
- 1420-682X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Five patients with severe Parkinson's disease were characterized with respect to their pharmacokinetic and pharmacodynamic responses to levodopa given: orally, intravenously (three different infusion rates) and intraduodenally. The best therapeutic infusion rate in the intravenous study was used for
## Abstract Our purpose was to measure the change in quality of life (QoL) following deep brain stimulation of the globus pallidus interna (GPiβDBS) in advanced Parkinson 's disease (PD), and identifies any associations with changes in motor features of the disease. Eleven patients (age range 54β69
Tranquillizers, and specifically benzodiazepines (BZD), have become one of the most widely used group of drugs in the world; some have suggested too widely used. Interest in these drugs is still extremely high, both from the scientific and sociological point of view. This is best documented by the f